Efficacy of terbinafine 1% cream on seborrhoeic dermatitis

Journal of Dermatology

Volumn 32, Issue 1, 2005, Pages 22-25

  Gündüz, Kamer ^a,b   Inanir, Isil ^a   Sacar, Handan ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Merkez Efendi Mah   (Turkey)

Author keywords

Antifungal agents; Seborrhoeic dermatitis; Terbinafine; Treatment

Indexed keywords

ANTIFUNGAL AGENT; TERBINAFINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; MALASSEZIA; MALE; REMISSION; SCORING SYSTEM; SEBORRHEIC DERMATITIS; SIDE EFFECT; SKIN MANIFESTATION; STATISTICAL ANALYSIS; VISUAL ANALOG SCALE;

EID: 14644400511     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00708.x     Document Type: Article

References (19)

1. Johnson BA, Nunley JR: Treatment of seborrheic dermatitis, Am Fam Physician, 61: 2703-2710, 2000.
2. Faergemann J, Jones TC, Hettler O, Loria Y: Malassezia ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options, Br J Dermatol, 134 (Suppl. 46): 12-15, 1996.
3. Heng MCY, Henderson CL, Barker DC, Haberfelde G: Correlation of Malassezia ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique, J Am Acad Dermatol, 23: 82-86, 1990.
4. Parry ME, Sharpe GR: Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast, Br J Dermatol, 139: 254-263, 1998.
5. Inalöz HS, Kirtak N: The pathogenesis and treatment of seborrhoeic dermatitis, T Klin J Med Sci, 22:239-244, 2002.
6. Green CA, Farr PM, Shuster S: Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole, BrJ Dermatol, 116: 217-221, 1987.
7. Ford GP, Farr PM, Ive FA, Shuster S: The response of seborrhoeic dermatitis to ketoconazole, Br J Dermatol, 3: 603-607, 1984.
8. Scaparro E, Quadri G, Virno G, Orifici C, Milani M: Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled tiral, Br J Dermatol, 144: 854-857, 2001.
9. Cassano N, Amoruso A, Loconsole F, Vena GA: Oral terbinafine for the treatment of seborrhoeic dermatitis in adults, Int J Dermatol, 41: 821-822, 2002.
10. Faergemann J: Treatment of seborrhoeic dermatitis with oral terbinafine, Lancet, 358: 170, 2001.
11. Faergemann J: Management of seborrheic dermatitis and pityriasis versicolor, Am J Clin Dermatol, 1: 75-80, 2000.
12. Pierard-Franchimont C, Pierard GE, Arrese JE, De Doncker P: Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis-Clinical, squamometric and mycological assessments, Dermatology, 202: 171-176, 2001.
13. Kanda N, Watanabe S: Ketoconazole suppresses interleukin-4 plus anti-CD40-induced IgE class switching in surface IgE negative B cells from patients with atopic dermatitis, J Invest Dermatol, 119: 590-599, 2002.
14. Kanda N, Enomoto U, Watanabe S: Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis, J Invest Dermatol, 117: 1635-1646, 2001.
15. Pierard-Franchimont C, Pierard GE: A double-blind placebo-controlled study of ketoconazole+desonide gel combination in the treatment of facial seborrheic dermatitis, Dermatology, 204: 344-347, 2002.
16. Squire RA, Goode K: A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seorrhoeic dermatitis, J Dermatol Treat, 13: 51-60, 2002.
17. Chosidow O, Maurette C, Dupuy P: Randomized, open-labeled, non-inferiority study between ciclopiroxalamine 1% cream and ketoconazole 2% foaming gel mild to moderate facial seborrheic dermatitis, Dermatology, 206: 233-240, 2003.
18. Petranyi G, Meingassner JG, Mieth H: Antifungal activity of the allylamine derivative terbinafine in vitro, Antimicrob Agents Chemother, 31: 1365-1368, 1987.
19. Leeming JP, Sansom JE, Burton JL: Susceptibility of Malassezia furfur subgroups to terbinafine, Br J Dermatol, 137: 764-767, 1997.